title: Feasibility of protein-sparing modified fast by tube (ProMoFasT) in obesity treatment: a phase II pilot trial on clinical safety and efficacy (appetite control, body composition, muscular strength, metabolic pattern, pulmonary function test).
abstract: Anecdotal data in the last few years suggest that protein-sparing modified diet (PSMF) delivered by naso-gastric tube enteral (with continuous feeding) could attain an significant weight loss and control of appetite oral feeding, but no phase II studies on safety and efficacy have been done up to now. To verify the safety and efficacy of a protein-sparing modified fast administered by naso-gastric tube (ProMoFasT) for 10 days followed by 20 days of a low-calorie diet, in patients with morbid obesity (appetite control, fat free mass maintenance, pulmonary function tests and metabolic pattern, side effects), 26 patients with a BMI ≥30 kg/m2have been selected. The patients had to follow a protein-sparing fast by enteral nutrition (ProMoFasT) for 24 h/day, for 10 days followed by 20 days of low-calorie diet (LCD). The endpoint was represented by body weight, BMI, abdominal circumference, Haber's appetite test, body composition by body impedance assessment (BIA), handgrip strength test, metabolic pattern, pulmonary function test. Safety was assessed by evaluation of complications and side effects of PSMF and/or enteral nutrition. In this report the results on safety and efficacy are described after 10 and 30 days of treatment. After the recruiting phase, a total of 22 patients out of 26 enrolled [14 (63.6 %) females] were evaluated in this study. Globally almost all clinical parameters changed significantly during first 10 days. Total body weight significantly decreased after 10 days (∆-6.1 ± 2;p< 0.001) and this decrease is maintained in the following 20 days of LCD (∆ = -5.88 ± 1.79;p< 0.001). Also the abdominal circumference significantly decreased after 10 days [median (range): -4.5 (-30 to 0);p< 0.001] maintained then in the following 20 days of LCD [median (range) = -7 (-23.5 to -2);p< 0.001]. All BIA parameters significantly changed after 10 and 30 days from baseline. All parameters except BF had a significant change after 10 days of treatment while the difference at 30 days was lower than at 10 days for TBW, FFM and MM with no significant differences from baseline for the last two characteristics. For VAS appetite the difference was significant after 10 days and the decrease in appetite was maintained at 30 days with no significant difference (p= 0.83) between 10 and 30 days. No significant differences in the first 30 days were detected for PA and for both left and right hand grip strength. Particularly, a significant reduction of 1.82 kg in FFM after 10 days was detected, but not after 30 days. In contrast, a decrease of 3.8 kg of BF is observed after 30 days. As far as the respiratory functional tests (RFT) are concerned, a significant difference at 10 days was globally observed for functional residual capacity (p= 0.012) and expiratory reserve volume (p= 0.025). There are no reported major complications and side effects resulting from the enteral nutrition or PSMF. In particular, cardiac arrhythmias have not been reported. From the clinical point of view the PSMF with naso-gastric tube (ProMoFasT) method appears safe, it is associated with a significant weight loss related to decrease of FM and not to loss of FFM and appetite decreases. It is relevant that the RFT are significantly improved after only 10 days suggesting the efficacy of this regime in short period, too. These preliminary data underline the necessity to increase the number of RCT for this method, which could represent a possible alternative to other methodologies, such as the intragastric balloon, in particular when it is recommended to improve RFT before bariatric, gynecological, orthopedic and lymphatic surgery.
authors.affiliation: Clinical Nutrition Unit, IRCCS San Martino University Hospital, National Cancer Institute, Largo R. Benzi 2, 16122 Genoa, Italy.
authors.forename: S G
authors.initials: SG
authors.lastname: Sukkar
authors.forename: A
authors.initials: A
authors.lastname: Signori
authors.forename: C
authors.initials: C
authors.lastname: Borrini
authors.forename: G
authors.initials: G
authors.lastname: Barisione
authors.forename: C
authors.initials: C
authors.lastname: Ivaldi
authors.forename: C
authors.initials: C
authors.lastname: Romeo
authors.forename: R
authors.initials: R
authors.lastname: Gradaschi
authors.forename: N
authors.initials: N
authors.lastname: Machello
authors.forename: E
authors.initials: E
authors.lastname: Nanetti
authors.forename: A L
authors.initials: AL
authors.lastname: Vaccaro
keywords: Appetite; Enteral nutrition; Hand grip strength; Ketogenic diet; NEP; Obesity; PSMF; ProMoFasT; Protein; Protein-sparing modified fasting by tube; Pulmonary function test; Tube feeding; VLCD
references.citation: Am J Clin Nutr. 2004 May;79(5):899S-906S
references.pmid: 15113737
references.citation: Eur Respir J. 2005 Sep;26(3):511-22
references.pmid: 16135736
references.citation: Circulation. 1979 Dec;60(6):1401-12
references.pmid: 498466
references.citation: Am J Clin Nutr. 2006 Feb;83(2):260-74
references.pmid: 16469983
references.citation: Chest. 2000 Nov;118(5):1315-21
references.pmid: 11083680
references.citation: Obes Surg. 1992 Feb;2(1):33-40
references.pmid: 10765160
references.citation: Br J Nutr. 2008 Feb;99(2):432-41
references.pmid: 17894918
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004931
references.pmid: 17253531
references.citation: J Nutr. 2004 Oct;134(10):2646-52
references.pmid: 15465761
references.citation: Obes Res. 2005 May;13(5):845-54
references.pmid: 15919837
references.citation: Am J Clin Nutr. 2005 Jan;81(1):79-86
references.pmid: 15640464
references.citation: J Clin Invest. 1992 Jan;89(1):169-75
references.pmid: 1729269
references.citation: Am J Clin Nutr. 1991 Feb;53(2):430-6
references.pmid: 1989409
references.citation: Clin Physiol. 1996 May;16(3):229-38
references.pmid: 8736711
references.citation: Int J Obes. 1987;11(3):239-49
references.pmid: 3667060
references.citation: J Clin Invest. 1977 Feb;59(2):299-307
references.pmid: 833277
references.citation: Physiol Rev. 2000 Apr;80(2):649-80
references.pmid: 10747204
references.citation: Ann Intern Med. 2004 May 18;140(10):769-77
references.pmid: 15148063
references.citation: Eur Respir J. 2005 Oct;26(4):720-35
references.pmid: 16204605
references.citation: Ann Intern Med. 2005 Mar 15;142(6):403-11
references.pmid: 15767618
references.citation: Eur Respir J. 2005 Aug;26(2):319-38
references.pmid: 16055882
references.citation: Diabetes. 1976 Jun;25(6):494-504
references.pmid: 1278601
references.citation: Am Rev Respir Dis. 1973 Oct;108(4):831-42
references.pmid: 4741877
references.citation: Adv Ther. 1998 Sep-Oct;15(5):305-14
references.pmid: 10345151
references.citation: Metabolism. 1984 Mar;33(3):219-23
references.pmid: 6694561
references.citation: Am J Clin Nutr. 1996 Sep;64(3 Suppl):423S-427S
references.pmid: 8780358
references.citation: Physiol Behav. 2002 Aug;76(4-5):623-31
references.pmid: 12127002
references.citation: Eur Respir J Suppl. 1993 Mar;16:41-52
references.pmid: 8499053
references.citation: J Nutr. 1986 May;116(5):918-20
references.pmid: 3701464
references.citation: Eur Respir J Suppl. 1993 Mar;16:5-40
references.pmid: 8499054
references.citation: Am Rev Respir Dis. 1983 Sep;128(3):501-6
references.pmid: 6614644
references.citation: Curr Atheroscler Rep. 2003 Nov;5(6):476-83
references.pmid: 14525681
references.citation: Obes Res. 1997 May;5(3):250-6
references.pmid: 9192399
references.citation: Metabolism. 1997 Aug;46(8):968-75
references.pmid: 9258284
references.citation: Int J Obes Relat Metab Disord. 1995 May;19(5):343-6
references.pmid: 7647827
references.citation: J Am Coll Nutr. 2002 Jun;21(3):259-67
references.pmid: 12074254
references.citation: Obes Rev. 2008 Jul;9(4):326-39
references.pmid: 18331421
references.citation: Br Med J. 1974 Aug 10;3(5927):391-3
references.pmid: 4854081
references.citation: Br J Nutr. 2003 Nov;90(5):953-60
references.pmid: 14667188
references.citation: J Clin Invest. 1996 Jul 15;98(2):378-85
references.pmid: 8755648
references.citation: Chest. 2004 Jun;125(6):2046-52
references.pmid: 15189920
references.citation: Obes Res. 1999 Nov;7(6):597-604
references.pmid: 10574520
references.citation: BMJ. 2000 Mar 25;320(7238):827-32
references.pmid: 10731173
references.citation: Ann N Y Acad Sci. 2000 May;904:359-65
references.pmid: 10865771